Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-18

FDA Approved: AZELASTINE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved the original application for azelastine, a generic antihistamine, submitted by Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZELASTINE (Azelastine)

Snippet

ORIG AP for AZELASTINE (AZELASTINE)